CAS No.:14636-12-5

TOXICITY DATA with REFERENCE：

 

Consensus Reports：

 

SAFETY PROFILE：

 

Standards and Recommendations：

 

Analytical Methods：

Terlipressin is a synthetic analog of vasopressin and is used as a vasoactive drug in the management of hypotension. It is a prodrug, which is converted to (Lys8)- vasopressin after removal of the N-terminal triglycine in vivo. Terlipressin has a longer duration of action and a better safety profile than the parent compound.